On this page you will find proposed changes that are currently going through the GMMMG approval process. This will include consultations on proposed RAG status, updated Formulary Chapters, Pathways or other GMMMG Guidance. You can comment on current proposals via the links in the table below.

If you have any problems or questions about consultations please email nuth.enquires.gmmmg@nhs.net.

Title Information Feedback End Date
GMMMG Clinical Reference Group proposed actions from November 2021 Updated 3rd December 2021 to assign a Green RAG status to inclisiran, as agreed by GMMMG at their meeting on 11th November 2021
On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the October 2021 CRG meeting. This consultation period is open until 5pm on Thursday 23rd December 2021
Feedback Form December 23rd, 2021
High Cost Drugs Pathway - Inflammatory Bowel Disease On behalf of the GMMMG IBD working group, we now seek comments on this draft version of the updated GM high cost drug IBD pathway. This consultation period is open until 5pm Wednesday 22nd December 2021. Feedback Form December 22nd, 2021
GMMMG Clinical Reference Group proposed actions from October 2021
[link removed - consultation closed]
On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the October 2021 CRG meeting. This consultation period is open until 5pm Tuesday 30th November 2021 [link removed - consultation closed] November 30th, 2021